Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cairns

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Proteomics|February 8, 2011
Statistical issues in quality control of proteomic analyses: good experimental design and planningDavid A Cairns
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2014
Statistical issues in the design and planning of proteomic profiling experimentsDavid A Cairns
Diagnostic and Prognostic Research|August 4, 2021
The development and validation of prognostic models for overall survival in the presence of missing data in the training dataset: a strategy with a detailed exampleKara-Louise Royle, David A Cairns
The Journal of Bone and Joint Surgery. American Volume|April 8, 2004
Primary nonoperative treatment of displaced lateral fractures of the clavicleC Michael Robinson, David A Cairns
Statistical Applications in Genetics and Molecular Biology|March 4, 2008
Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controlsJennifer H Barrett, David A Cairns
The New England Journal of Medicine|December 3, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia. ReplyTalha Munir, David A Cairns, Peter Hillmen
Journal of the American College of Cardiology|October 15, 2016
Reply: Potential Risk of Increased Risk of Falls Associated With High Doses of Vitamin D TreatmentRowena Byrom, David A Cairns, Klaus K Witte
JAMA Oncology|September 2, 2021
Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population-ReplyPeter S Hall, David A Cairns, Matthew T Seymour
The Lancet. Healthy Longevity|November 10, 2022
Defining FiTNEss for treatment for multiple myelomaGordon Cook, Charlotte Pawlyn, David A Cairns, et al.
Trials|November 5, 2023
How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic reviewKara-Louise Royle, David Meads, Jennifer K Visser-Rogers, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Proteomics|February 8, 2011
Statistical issues in quality control of proteomic analyses: good experimental design and planningDavid A Cairns
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2014
Statistical issues in the design and planning of proteomic profiling experimentsDavid A Cairns
Diagnostic and Prognostic Research|August 4, 2021
The development and validation of prognostic models for overall survival in the presence of missing data in the training dataset: a strategy with a detailed exampleKara-Louise Royle, David A Cairns
The Journal of Bone and Joint Surgery. American Volume|April 8, 2004
Primary nonoperative treatment of displaced lateral fractures of the clavicleC Michael Robinson, David A Cairns
Statistical Applications in Genetics and Molecular Biology|March 4, 2008
Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controlsJennifer H Barrett, David A Cairns
The New England Journal of Medicine|December 3, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia. ReplyTalha Munir, David A Cairns, Peter Hillmen
Journal of the American College of Cardiology|October 15, 2016
Reply: Potential Risk of Increased Risk of Falls Associated With High Doses of Vitamin D TreatmentRowena Byrom, David A Cairns, Klaus K Witte
JAMA Oncology|September 2, 2021
Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population-ReplyPeter S Hall, David A Cairns, Matthew T Seymour
The Lancet. Healthy Longevity|November 10, 2022
Defining FiTNEss for treatment for multiple myelomaGordon Cook, Charlotte Pawlyn, David A Cairns, et al.
Trials|November 5, 2023
How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic reviewKara-Louise Royle, David Meads, Jennifer K Visser-Rogers, et al.
Pageof 10